Aurinia Pharmaceuticals SG&A Expense (Quarterly) Trends

Aurinia Pharmaceuticals Inc (AUPH)

7.29 +0.13 (+1.82%) USD | NASDAQ | Sep 27, 16:00

7.29 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1999. Upgrade now.

Date	Value
June 30, 2024	42.28M
March 31, 2024	44.85M
December 31, 2023	50.07M
September 30, 2023	47.76M
June 30, 2023	43.64M
March 31, 2023	46.30M
December 31, 2022	47.47M
September 30, 2022	52.17M
June 30, 2022	51.53M
March 31, 2022	45.20M
December 31, 2021	44.76M
September 30, 2021	44.64M
June 30, 2021	44.32M
March 31, 2021	39.80M
December 31, 2020	40.07M
September 30, 2020	30.70M
June 30, 2020	15.45M
March 31, 2020	11.05M
December 31, 2019	7.43M
September 30, 2019	6.061M
June 30, 2019	4.946M
March 31, 2019	3.901M
December 31, 2018	3.518M
September 30, 2018	2.923M
June 30, 2018	3.462M

Date	Value
March 31, 2018	3.791M
December 31, 2017	3.118M
September 30, 2017	2.65M
June 30, 2017	2.901M
March 31, 2017	3.427M
December 31, 2016	2.227M
September 30, 2016	1.716M
June 30, 2016	1.835M
March 31, 2016	1.192M
December 31, 2015	1.564M
September 30, 2015	1.38M
June 30, 2015	1.414M
March 31, 2015	1.905M
December 31, 2014	1.399M
September 30, 2014	1.405M
June 30, 2014	1.713M
March 31, 2014	2.373M
December 31, 2013	0.821M
September 30, 2013	0.492M
June 30, 2013	0.491M
March 31, 2013	0.494M
December 31, 2012	0.9029M
September 30, 2012	0.9896M
June 30, 2012	0.9743M
March 31, 2012	0.9883M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

6.061M

Minimum

Sep 2019

52.17M

Maximum

Sep 2022

37.78M

Average

44.48M

Median

SG&A Expense (Quarterly) Benchmarks